Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Frailty × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 21 Genitourinary 8 Other hematologic neoplasm 5 Gynecologic 5 Breast 4 Thoracic 2 Plasma cell 2 NET 1 Myeloid 1 Lymphoid 1 Head & Neck 1 Endocrine 1

Conditions

Neuroendocrine Tumors 323 Carcinoid Tumor 33 Gastro-enteropancreatic neuroendocrine tumor 30 Neoplasms 23 Carcinoma, Neuroendocrine 23 Pancreatic Neoplasms 21 Adenoma, Islet Cell 20 Neoplasm Metastasis 15 Stomach Neoplasms 14 Pheochromocytoma 14 Paraganglioma 14 Gastrointestinal Neoplasms 13 Neuroblastoma 12 Prostatic Neoplasms 11 Carcinoma, Hepatocellular 11 Thyroid Neoplasms 10 Sarcoma 9 Lung Neoplasms 9 Esophageal Neoplasms 9 Colorectal Neoplasms 9 Breast Neoplasms 9 Anus Neoplasms 8 Gastrointestinal Stromal Tumors 7 Carcinoma 7 Adrenal Gland Neoplasms 7 Somatostatinoma 6 Serotonin Syndrome 6 Rectal Neoplasms 6 Liver Neoplasms 6 Insulinoma 6

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05554003 2024-11-18

MeTe

European Institute of Oncology

Phase 2 Recruiting

Frailty, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡